Search results for: ripretinib

25 05, 2023

Collaborations – New Horizons GIST Conference

By |2023-06-14T15:29:47-04:00May 25th, 2023|Conferences, Fundraising, News, Research|

Our Spring to GIST Awareness Day Campaign Continues! Our spring fundraising campaign is all about Fueling GIST Research and we will be sharing examples of all the ways The Life Raft Group is involved [...]

19 04, 2023

NCCN GIST Guidelines 2023 – What You Need to Know as a GIST Patient

By |2023-06-04T12:00:20-04:00April 19th, 2023|Advocacy, News, Patient Support|

NCCN recently updated the clinical practice guidelines in oncology for medical professionals for several types of cancer including GIST. These guidelines are a set of evidence-based recommendations for the diagnosis, treatment, and management of various types of cancer and define the recommendations for management, care, and treatment of all cancers in the US. What do you need to know?

2 02, 2023

Progress in Precision Medicine for GIST Patients

By |2023-02-03T08:25:06-05:00February 2nd, 2023|Clinical Trials, Drug Treatment, News|

These new data were presented by Dr. Sebastian Bauer and Dr. Breelyn A. Wilky during the 2023 January ASCO Plenary Series from the INTRIGUE Efficacy Results of ctDNA Analysis for GIST Patients.

4 01, 2023

Deciphera Announces New Results from Analysis from Intrigue Study

By |2023-01-04T11:40:28-05:00January 4th, 2023|News, Qinlock|

Deciphera issued a press release today sharing the results of an exploratory analysis of data using circulating tumor DNA (ctDNA) from the INTRIGUE Phase 3 clinical study of ripretinib and announcing plans to initiate INSIGHT.

Need a new search?

If you didn't find what you were looking for, try a new search!

Go to Top